PRESIDENT & CEO, DARÉ BIOSCIENCE
Sabrina Martucci Johnson founded Daré Bioscience in 2015 and has served as the women’s reproductive healthcare company’s leader since its inception. This year, the company entered into a license agreement with Hennepin Life Sciences under which Daré acquired the exclusive global rights to develop and commercialize treatments delivering antimicrobial glycerol monolaurate intravaginally for a variety of vaginal health conditions including bacterial, fungal and viral infections.
